VTX958 + VTX958 + VTX958 Placebo
Phase 2Terminated 0 watching 0 views this week⚡ Active
47
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Crohn Disease
Conditions
Crohn Disease
Trial Timeline
Jan 25, 2023 → Dec 20, 2024
NCT ID
NCT05688852About VTX958 + VTX958 + VTX958 Placebo
VTX958 + VTX958 + VTX958 Placebo is a phase 2 stage product being developed by Ventyx Biosciences for Crohn Disease. The current trial status is terminated. This product is registered under clinical trial identifier NCT05688852. Target conditions include Crohn Disease.
Hype Score Breakdown
Clinical
17
Activity
12
Company
5
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05688852 | Phase 2 | Terminated |
Competing Products
20 competing products in Crohn Disease